Truist Financial
EBS icon

Truist Financial’s Emergent Biosolutions EBS Stock Holding History

Truist Financial’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Sell
43,671
-30,362
-41% -$254K ﹤0.01% 2420
2026
Q1 		$614K Sell
74,033
-145,419
-66% -$1.51M ﹤0.01% 1956
2025
Q4 		$2.71M Sell
219,452
-49,842
-19% -$534K ﹤0.01% 1128
2025
Q3 		$2.38M Sell
269,294
-92,743
-26% -$721K ﹤0.01% 1250
2025
Q2 		$2.31M Buy
362,037
+26,608
+8% +$152K ﹤0.01% 1203
2025
Q1 		$1.63M Buy
335,429
+250,236
+294% +$2.07M ﹤0.01% 1312
2024
Q4 		$814K Sell
85,193
-59,003
-41% -$541K ﹤0.01% 1642
2024
Q3 		$1.2M Buy
144,196
+12,670
+10% +$115K ﹤0.01% 1440
2024
Q2 		$897K Buy
131,526
+14,360
+12% +$61.8K ﹤0.01% 1664
2024
Q1 		$296K Buy
117,166
+3,500
+3% +$7.89K ﹤0.01% 2296
2023
Q4 		$273K Buy
113,666
+3,595
+3% +$8.45K ﹤0.01% 2363
2023
Q3 		$374K Buy
+110,071
New +$610K ﹤0.01% 2088
2021
Q2 		– Sell
-7,059
Closed -$656K – 2729
2021
Q1 		$656K Buy
7,059
+1,745
+33% +$179K ﹤0.01% 1827
2020
Q4 		$476K Buy
5,314
+1,188
+29% +$109K ﹤0.01% 1872
2020
Q3 		$426K Buy
+4,126
New +$445K ﹤0.01% 1806

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Truist Financial's EBS Position: Q2 2026 in Review

Truist Financial reduced its Emergent Biosolutions (EBS) stake by 41% in Q2 2026, selling an estimated $254K and leaving 43,671 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Truist Financial first reported a position in EBS in Q3 2020 and has held it in 15 quarters since. The position peaked at $2.71M in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Truist Financial held 43,671 shares of Emergent Biosolutions worth $366K as of Q2 2026.
  • Truist Financial sold 30,362 Emergent Biosolutions shares in Q2 2026, an estimated $254K.
  • Emergent Biosolutions made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2420 holding.
  • Truist Financial first reported a position in Emergent Biosolutions in Q3 2020 and has held it in 15 quarters since.
  • Truist Financial's Emergent Biosolutions position peaked at $2.71M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.